Director - Veterinary Clinical Pathologist

Eli Lilly & Company is seeking a versatile and energetic veterinary clinical pathologist to work in drug discovery and development at the Lilly Corporate Center in Indianapolis, IN. The selected individual will join a talented group of pathologists reporting to the Senior Director of Pathology in the Division of Toxicology and Pathology. They will work independently and collaboratively in cross‑functional drug discovery and development teams within Lilly and with external partners to provide scientific leadership in interpreting toxicity and pharmacologic effects caused by biopharmaceuticals.

The successful candidate will contribute to the design, conduct, interpretation, and peer review of clinical pathology‑related endpoints in animal studies supporting drug development, including pharmacology and toxicology studies. A key expectation is to identify and bring solutions to pathology and toxicology issues affecting the discovery and development of potential biopharmaceuticals. This will be accomplished by working with a coordinated team of anatomic pathologists, toxicologists, nonclinical study managers, and other scientists.

The role involves frequent interaction with external business partners, particularly assessing laboratory capabilities, validating assays, developing biomarkers, and/or outsourcing to meet drug development team needs, and peer reviewing study results. The candidate must have strong communication and engagement skills to partner with a world‑class organization of scientists and leverage translational and comparative medicine expertise to positively impact projects in Lilly’s portfolio.

• DVM or equivalent degree and certification by the American College of Veterinary Pathologists (Clinical Pathology)
• Minimum of 7 years of experience in evaluating, interpreting, and reporting GLP and non‑GLP clinical pathology data from nonclinical toxicity studies

• Experience in integrating clinical and anatomic pathology data from nonclinical toxicity studies
• Experience in the evaluation and reporting of pathology data from animal models of human disease or other types of drug discovery studies
• Clear and concise oral and written communication, particularly of pathology data
• Ability to work individually or effectively in cross‑functional teams on issues related to drug discovery and development
• Development of scientific and regulatory perspectives on emerging issues and excellent problem‑solving skills
• Experience working with multiple therapeutic modalities
• Training or certification in anatomic pathology
• Ability to travel to Lilly business partners and regulatory agencies to conduct Lilly Toxicology and Pathology business
• Familiarity with biomarker development practices, designing validation studies, and authoring reports

Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions. If you require accommodation to submit a resume for a position at Lilly, please complete the accommodation request form () for further assistance. Please note this is for individuals to request an accommodation as part of the application process and any other correspondence will not receive a response.

Lilly is proud to be an EEO Employer and does not discriminate on the basis of age, race, color, religion, gender identity, sex, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status.

Actual compensation will depend on a candidate’s education, experience, skills, and geographic location. The anticipated wage for this position is $169,500 - $312,400. Full‑time equivalent employees also will be eligible for a company bonus (depending, in part, on company and individual performance). In addition, Lilly offers a comprehensive benefit program to eligible employees, including eligibility to participate in a company‑sponsored 401(k);

pension; vacation benefits; eligibility for medical, dental, vision and prescription drug benefits; flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts); life insurance and death benefits; certain time off and leave of absence benefits; and well‑being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities). Lilly reserves the right to amend, modify, or terminate its compensation and benefit programs in its sole discretion and Lilly’s compensation practices and guidelines will apply regarding the details of any promotion or transfer of Lilly employees.